Projected top drug makers globally by revenue 2019

This statistic depicts the probable top 10 pharmaceutical companies by revenue in 2019 after the completion of the Takeda-Shire deal. After this deal, the new Takeda-Shire company would become one of the top 10 pharma companies globally. The same would be true for Bristol-Myers Squibb, if the deal with Celgene should be completed.

Probable top 10 pharmaceutical companies by revenue in 2019 after Takeda-Shire deal

Revenue in billion U.S. dollars
Exclusive Premium statistic

You need a Single Account for unlimited access.

  • Full access to 1m statistics

  • Incl. source references

  • Available to download in PNG, PDF, XLS format

Single Account

only $59 / month *
*Duration: 12 months, billed annually, single license

Access to this and all other statistics on 80,000 topics from

$708 / Year

Show detailed source information?
Register for free
Already a member?
Log in

Release date

January 2019



Survey time period

as of January 2019

Supplementary notes

Estimates are based on the companies' filings for the most-recent fiscal year.
* BMS and Celgene's combined revenue dependent on deal completion; Exchange rates used are as of Jan. 4, 2019.

Statista Accounts: Access All Statistics. Starting from $708 / Year
Basic Account
Get to know the platform

You only have access to basic statistics.
This statistic is not included in your account!

Single Account
Your perfect start with Statista
  • Instant access to 1m statistics
  • Download in XLS, PDF & PNG format
  • Detailed references

$59 / Month *

Corporate Account
Full access

Corporate solution including all features.

* All products require an annual contract.
   Prices do not include sales tax.

Statistics on "Pharmaceutical trends in Europe"

Statista Accounts: Access All Statistics. Starting from $708 / Year
Learn more about how Statista can support your business.